From the Literature

 

Published: Jun 2016

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
Larsen TB, Skjøth F, Nielsen PB, Kjældgaard JN, Lip GY
BMJ 2016;353:i3189.
Pub Med
NATA rating :

 

REVIEW by:
B. J. Hunt

 

NATA REVIEW:
Another article providing real-world data on DOACs compared with warfarin. Helpful also in comparing efficacy and safety between DOACs. This is an evloving story, with this picture being a major piece in the jigsaw.

- Beverley J. Hunt